Cointime

Origene Technologies

company

About

OriGene Technologies is a research tool company that provides a commercial collection of full-length human cDNAs.

  • 501 - 1000

Highlights

Total Funding Amount
$16M
Funding Rounds
2
Investors
3

Details

Last Funding Type
Grant
Industries
Biotechnology,Genetics,Medical Device,Pharmaceutical
Founded date
Jan 1, 1996
Number Of Employee
501 - 1000
Operating Status
Active

OriGene Technologies was founded as a research tool company focused on the creation of the largest commercial collection of full-length human cDNAs. It strives to fulfill its mission of supplying everything a researcher needs for gene-based research. Through licensing and selling research materials including genes, proteins, and research tools, it enables critical biological research.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$16M
Origene Technologies has raised a total of $16M in funding over 2 rounds. Their latest funding was raised on Mar 24, 2010 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 24, 2010 Series B $16M 2 Zero2IPO Capital
SBI & TH Venture Capital Enterprise 		— Detail
Sep 23, 2004 Grant — 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
2
3
Origene Technologies is funded by 3 investors. Zero2IPO Capital and SBI & TH Venture Capital Enterprise are the most recent investors.
Investor Name Lead Investor Funding Round
Zero2IPO Capital Yes Series B
SBI & TH Venture Capital Enterprise Yes Series B
National Institutes of Health — Grant
Cointime
เนื้อหา
บริษัท